📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-09-09 14:42
122 analysed today
FollowTelegram
122
Today
149,523
All-time analysed
42,890
Positive
6,652
Negative
91,308
Neutral
8,605
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
31 announcements match the current filters (relevance ≥ 5).
IVP Updates on Employee Fraud Matter: Accused Files Writ Petition Against Company's FIR
IVP Limited has announced an update regarding an ongoing employee fraud matter under SEBI Regulation 30. The accused individual, Ravi Ranjan Jha, has filed a Writ Petition challenging the FIR and legal proceedings initiated by the company. IVP stated it is taking necessary legal steps to safeguard its interests, with no financial exposure quantified in this disclosure. Given IVP's TTM net profit of Rs 7 Cr and market cap of Rs 222 Cr, any unrecovered losses from the fraud remain an area to monitor.
Confidence: HIGH
What changedThe accused employee in an ongoing fraud case has filed a Writ Petition challenging IVP's legal proceedings and FIR.
Why it mattersWhile procedural, fraud investigations can highlight internal control gaps and potentially result in financial write-offs relative to the company's Rs 7 Cr annual PAT.
Announcement date: September 9, 2026TTM Net Profit (context): Rs 7 CrMarket capitalization (context): Rs 222 CrQuantum of fraud: not disclosed
📅 Short termLimited immediate operational impact, but creates legal overhead and legal costs pending court hearings on the Writ Petition.
📈 Long termStructural significance hinges on whether internal control lapses led to material financial losses and whether processes are overhauled.
⚠ Risk flags
- Unquantified financial loss from employee fraud
- Litigation delay from Writ Petition
Key Highlights
Intimation filed on September 9, 2026, under Regulation 30(7) of SEBI LODR Regulations
Accused employee Ravi Ranjan Jha filed a Writ Petition against the FIR and legal actions initiated by IVP
Company is pursuing legal steps to protect its interests; further updates to be disclosed as they occur
Financial quantum of the fraud was not disclosed in the filing
👀 What to Watch
Track subsequent legal disclosures and quarterly filings to ascertain the quantified financial impact and recovery prospects of the alleged fraud.
Bombay HC Quashes MBPA Retrospective Rent Demands from 2012 to March 2024
The Hon'ble Bombay High Court has ruled in favor of IVP Limited in Writ Petition No. 3530 of 2022 against the Mumbai Port Authority (MBPA). The court quashed all notifications, orders, and demand notices seeking revised Scale of Rates (SOR) and retrospective rent arrears from 2012 up to March 31, 2024. Rent payable up to March 31, 2024 will continue under Compromise Proposal rates. For the period starting April 1, 2024, MBPA is permitted to determine rent provided it is fair, reasonable, and non-profiteering.
Confidence: HIGH
What changedBombay High Court set aside all retrospective lease rent increase demands from MBPA covering 2012 through March 31, 2024.
Why it mattersEliminates a substantial contingent liability and potential cash outflow for 12 years of retrospective lease arrears, safeguarding net worth (Rs 157 Cr) and cash flows.
Period of quashed retrospective demands: 2012 to March 31, 2024Writ Petition Number: 3530 of 2022Effective date for fresh rent fixation: April 1, 2024Company TTM PAT context: Rs 7 Cr
📅 Short termClear legal positive removing a prolonged overhang regarding legacy leasehold land arrears.
📈 Long termEliminates legacy liability risks, though prospective operational costs will depend on the fair rent rate determined by MBPA starting FY25.
⚠ Risk flags
- Potential appeal by Mumbai Port Authority before the Supreme Court
- Unquantified rent rate escalation for periods post April 1, 2024
Key Highlights
Bombay High Court quashed MBPA demand notices and revised SOR seeking retrospective arrears from 2012 to March 31, 2024.
Rent up to March 31, 2024 confirmed to continue under Compromise Proposal rates upheld by the Supreme Court.
MBPA permitted to fix fresh rent from April 1, 2024 onwards under fair, reasonable, and non-profiteering principles.
👀 What to Watch
Monitor whether MBPA files a special leave petition (SLP) before the Supreme Court and watch for the finalization of new lease terms effective from April 1, 2024.
UNIVPHOTO Q1 Results: Net Profit of ₹6.95 Cr Supported by ₹7.44 Cr Other Income
Universus Photo Imagings reported a standalone net profit of ₹6.95 Cr for Q1 FY27 (June 2026), down from ₹8.93 Cr in the year-ago period. Revenue from operations grew slightly to ₹5.48 Cr compared to ₹4.97 Cr in June 2025, but the company remains heavily dependent on 'Other Income' (₹7.44 Cr), which exceeded core operational revenue. The board also approved the re-appointment of Mr. Sanjeev Aggarwal as an Independent Director for a second 5-year term. Despite the quarterly profit, the company faces structural challenges as its core X-ray film business is threatened by digital diagnostics.
Confidence: HIGH
What changedThe company reported its Q1 FY27 financial results and confirmed the re-appointment of an Independent Director and Internal Auditor.
Why it mattersThe results show a return to quarterly profit after a heavy TTM loss of ₹80 Cr, but the low operational revenue (₹5.48 Cr) relative to the ₹521 Cr market cap suggests the valuation is driven by assets or investments rather than core business growth.
Q1 Revenue from Operations: ₹5.48 CrQ1 Other Income: ₹7.44 CrQ1 Net Profit: ₹6.95 CrOther Income as % of Total Revenue: 57.6%TTM Net Profit: ₹-80 Cr
📅 Short termThe stock may see neutral to slightly positive sentiment due to the reported quarterly profit, though the reliance on non-core income limits the quality of the earnings.
📈 Long termThe long-term outlook remains cautious as the company must successfully transition its business model to offset the decline in physical X-ray film demand.
⚠ Risk flags
- Core business obsolescence
- High dependence on non-operating income
- Small operational scale relative to market capitalization
Key Highlights
Net Profit for the quarter ended June 30, 2026, stood at ₹6.95 Cr.
Revenue from operations was ₹5.48 Cr, representing approximately 28% of TTM revenue.
Other Income of ₹7.44 Cr accounted for 57.6% of the total revenue for the quarter.
Total expenses decreased to ₹4.71 Cr from ₹5.54 Cr in the corresponding quarter of the previous year.
Re-appointment of Independent Director Sanjeev Aggarwal approved for a 5-year term starting November 13, 2026.
👀 What to Watch
Investors should monitor the source of 'Other Income' and look for updates on the company's pivot to health-tech startups, as the core business continues to struggle with technological obsolescence.
Universus Photo Q1 FY27 Revenue at ₹5.48 Cr; Re-appoints Independent Director for 5 Years
Universus Photo Imagings reported standalone Q1 FY27 revenue of ₹5.48 Cr, a 10% increase from ₹4.97 Cr in Q1 FY26. Standalone profit for the period stood at ₹6.95 Cr, down from ₹8.93 Cr YoY, with profitability heavily supported by 'Other Income' of ₹7.44 Cr which exceeded core operational revenue. The board also approved the re-appointment of Mr. Sanjeev Aggarwal as an Independent Director for a second five-year term starting November 2026. The company remains in a structural transition as digitalization continues to impact its core X-ray film business.
Confidence: HIGH
What changedThe company has reported its first-quarter results for FY27 and confirmed the continuation of key board and audit personnel.
Why it mattersThe results confirm the company's ongoing reliance on non-operational income (Other Income) to sustain profitability while its core manufacturing business remains stagnant due to industry-wide digitalization.
Q1 FY27 Standalone Revenue: ₹5.48 CrQ1 FY27 Other Income: ₹7.44 CrQ1 FY27 Standalone PAT: ₹6.95 CrRevenue vs Market Cap: ~1.05%Independent Director Term: 5 Years
📅 Short termThe stock is likely to remain neutral in the short term as the earnings reflect a small-scale operation heavily dependent on non-core income.
📈 Long termLong-term value depends entirely on the company's ability to redeploy its significant net worth (₹668 Cr) into new growth areas, as the traditional X-ray film market is shrinking.
⚠ Risk flags
- Technological obsolescence of core X-ray film products
- High reliance on non-operational income for profitability
- Negative TTM consolidated PAT of ₹-80 Cr
Key Highlights
Standalone revenue from operations for Q1 FY27 was ₹5.48 Cr compared to ₹4.97 Cr in Q1 FY26.
Other Income of ₹7.44 Cr contributed significantly to the total revenue of ₹12.92 Cr in Q1 FY27.
Standalone Profit for the period was ₹6.95 Cr, a decline from ₹8.93 Cr in the corresponding previous quarter.
Mr. Sanjeev Aggarwal re-appointed as Independent Director for a 5-year term from Nov 13, 2026, to Nov 12, 2031.
Mr. Suresh Kumar re-appointed as Internal Auditor for the financial year 2026-27.
👀 What to Watch
Investors should monitor the company's progress in pivoting toward health-tech startups, as the core X-ray film business (₹19 Cr TTM revenue) is small relative to its ₹668 Cr net worth and faces technological obsolescence.
Rs 6.95 Cr Net Profit: UNIVPHOTO Reports Q1 FY27 Results and Board Appointments
Universus Photo Imagings reported a standalone net profit of Rs 6.95 Cr for the quarter ended June 30, 2026, a 22% decline from Rs 8.93 Cr in the same period last year. While revenue from operations grew slightly by 10.2% YoY to Rs 5.48 Cr, total revenue was impacted by a significant drop in 'Other Income' to Rs 7.44 Cr from Rs 11.04 Cr. The company continues to rely heavily on non-operational income, which accounted for 57.6% of total revenue this quarter. The board also confirmed the re-appointment of an Independent Director for a five-year term and an Internal Auditor for FY27.
Confidence: HIGH
What changedThe company reported its first-quarter results for FY27 and formalized the re-appointment of key management and audit personnel.
Why it mattersThe results highlight the ongoing challenge of technological obsolescence in the core X-ray film business, with the company's profitability currently sustained by financial assets rather than core sales.
Q1 Net Profit: Rs 6.95 CrQ1 Revenue from Ops: Rs 5.48 CrOther Income % of Total Revenue: 57.6%TTM Revenue vs Net Worth: ~2.8%
📅 Short termThe stock may remain range-bound as the decline in YoY profitability is offset by the fact that the company remains profitable despite a shrinking core market.
📈 Long termThe long-term outlook depends entirely on the successful deployment of its Rs 668 Cr net worth into new growth areas, as the traditional medical film business faces digital replacement.
⚠ Risk flags
- Technological obsolescence of core products
- High dependence on non-operating income
- Declining year-on-year profitability
Key Highlights
Standalone Net Profit stood at Rs 6.95 Cr for Q1 FY27 compared to Rs 8.93 Cr in Q1 FY26
Revenue from operations increased to Rs 5.48 Cr from Rs 4.97 Cr in the year-ago quarter
Other Income contributed Rs 7.44 Cr, significantly exceeding operational revenue of Rs 5.48 Cr
Total expenses were reduced to Rs 4.71 Cr from Rs 5.54 Cr YoY
Re-appointment of Mr. Sanjeev Aggarwal as Independent Director for a 5-year term until November 2031
👀 What to Watch
Monitor the company's progress in pivoting away from its obsolete X-ray film business toward the health-tech ecosystem. Investors should track whether operational revenue can eventually replace the high reliance on investment-led 'Other Income'.
SEBI Issues Show Cause Notice to Universus Photo Imagings Over Governance and Transactions
Universus Photo Imagings Limited received a Show Cause Notice (SCN) from SEBI on August 06, 2026, regarding observations on specific transactions and corporate governance issues. The notice is issued under multiple sections of the SEBI Act, 1992, including those related to fraudulent and unfair trade practices (15HA) and general penalties (15HB). The SCN involves the company, its promoters, and key management personnel. While no financial penalty has been quantified yet, the regulatory scrutiny is significant given the company's small TTM revenue of Rs 19 Cr and substantial TTM losses of Rs 80 Cr.
Confidence: HIGH
What changedSEBI has formally initiated a show-cause process against the company and its leadership regarding governance and transaction-related observations.
Why it mattersRegulatory scrutiny on governance is a major risk factor for a company already facing a declining core business (X-ray films) and heavy operational losses. It could impact the company's ability to pivot its business model or manage its Rs 668 Cr net worth.
Date of SCN receipt: August 06, 2026TTM Revenue: Rs 19 CrTTM Net Profit: Rs -80 CrNet Worth: Rs 668 CrPromoter Holding: 74.55%
📅 Short termThe stock may face downward pressure due to the uncertainty and negative sentiment associated with a SEBI show-cause notice involving promoters.
📈 Long termGovernance issues can lead to structural de-rating and legal complications that may hinder the company's strategic shift toward health-tech startups.
⚠ Risk flags
- Regulatory action
- Governance concerns
- Unquantified financial penalty
- Promoter/KMP involvement in SCN
Key Highlights
Show Cause Notice received from SEBI on August 06, 2026, via email.
Notice issued under Sections 11(1), 11(4), 11B(1), 15HA, 15HB, and 15A(a) of the SEBI Act, 1992.
The investigation pertains to certain transactions and matters of corporate governance involving promoters and KMPs.
Company's TTM revenue is just Rs 19 Cr, making any potential regulatory penalty highly material to its financial health.
The company is currently in the process of filing a reply to the regulatory authority.
👀 What to Watch
Monitor for the company's formal response to SEBI and any subsequent adjudication orders that may impose penalties or restrictions. Investors should evaluate the 'governance' risk in the context of the company's high promoter holding of 74.55%.
Q1 PAT Jumps 1078% to ₹14.02 Cr; ₹136.81 Cr Legal Demand Quashed
IVP Limited reported a stellar Q1 FY27 with net profit surging to ₹14.02 Cr from ₹1.19 Cr YoY, driven by a 12% revenue growth and significantly improved margins. A major legal risk was mitigated as the City Civil Court quashed a ₹136.81 Cr demand from the Mumbai Port Authority, which represented nearly 82% of the company's market cap. Operationally, the company successfully resolved a brief 10-day regulatory closure at its Tarapur unit in July 2026. The results reflect the company's strategic shift toward higher-margin flexible packaging solutions.
Confidence: HIGH
What changedIVP has delivered a massive earnings beat and successfully cleared a contingent liability that was nearly equal to its entire market capitalization.
Why it mattersThe resolution of the ₹136.81 Cr legal demand removes a significant existential threat to the company's balance sheet, while the profit jump validates the management's shift toward non-foam applications.
Q1 Net Profit: ₹14.02 CrQuashed Legal Demand: ₹136.81 CrDemand vs Market Cap: ~82.4%Q1 Revenue: ₹154.73 CrQ1 EPS: ₹13.57
📅 Short termThe stock is likely to react very positively to the combination of explosive profit growth and the removal of a massive legal overhang.
📈 Long termIf IVP can maintain these margins through its flexible packaging pivot, the business could undergo a structural re-rating from a commodity chemical player to a specialized solutions provider.
⚠ Risk flags
- Potential for legal appeal by Mumbai Port Authority
- Raw material price volatility in the chemical segment
Key Highlights
Net Profit increased 1078% YoY to ₹14.02 Cr in Q1 FY27.
Revenue from operations grew 12% YoY to ₹154.73 Cr.
City Civil Court quashed a ₹136.81 Cr eviction and damage demand on July 24, 2026.
Finance costs decreased by 34.6% YoY to ₹1.38 Cr.
Tarapur manufacturing unit resumed operations on July 9, 2026, after a brief MPCB closure.
👀 What to Watch
Monitor the sustainability of the current EBITDA margins as the company transitions to specialized packaging chemicals. Investors should also watch for any potential appeals by the Mumbai Port Authority against the recent court order.
Rs 1.5 Dividend: IVP Limited Sets July 30 as Record Date and Outlines TDS Procedures
IVP Limited has announced the procedural details for its FY 2025-26 dividend of Rs 1.5 per share, representing a 15% payout on the face value of Rs 10. The record date to determine eligibility is July 30, 2026, with the 97th Annual General Meeting scheduled for August 06, 2026. Shareholders must ensure their PAN is linked with Aadhaar to avoid a higher TDS rate of 20% instead of the standard 10%. Dividend payouts are expected to commence from August 10, 2026, following shareholder approval.
Confidence: HIGH
What changedThe company has formalized the timeline and tax-withholding protocols for its previously recommended FY26 dividend.
Why it mattersThis is a routine distribution of profits to shareholders, providing a dividend yield of approximately 0.95% based on the current market price of Rs 157.2.
Dividend per share: Rs 1.5Dividend Yield: ~0.95%Record Date: July 30, 2026AGM Date: August 06, 2026TDS Rate (with PAN): 10%TDS Exemption Limit (Residents): Rs 10,000
📅 Short termThe stock may see minor price adjustment on the ex-dividend date (typically one day before the record date); otherwise, the impact is expected to be neutral.
📈 Long termLimited; this is a routine annual corporate action and does not signal a structural change in business operations.
Key Highlights
Recommended dividend of Rs 1.5 per equity share for the financial year ended March 31, 2026.
Record date for determining shareholder eligibility is fixed for July 30, 2026.
Standard TDS rate of 10% for resident shareholders with valid PAN; 20% for those without or with unlinked Aadhaar.
Exemption from TDS for resident individuals if the total dividend received during the tax year does not exceed Rs 10,000.
Dividend payout is scheduled to begin from August 10, 2026, post-AGM approval.
👀 What to Watch
Shareholders should verify that their PAN is correctly linked to Aadhaar and that bank account details are updated in their demat accounts by July 30, 2026, to ensure accurate tax withholding and timely credit.
₹1.5 per share Final Dividend: IVP sets July 30, 2026 as Record Date
IVP Limited has announced a final dividend of ₹1.5 per equity share for the financial year 2025-26, representing a 15% payout on its ₹10 face value. The company has fixed July 30, 2026, as the record date to determine eligible shareholders. This dividend is subject to approval at the upcoming 97th Annual General Meeting (AGM) on August 6, 2026. Based on the TTM EPS of ₹6.57, the proposed dividend reflects a payout ratio of approximately 23%.
Confidence: HIGH
What changedThe company has finalized the record date and AGM schedule for its FY26 final dividend distribution.
Why it mattersThe dividend provides a tangible cash return to shareholders and signals management's confidence in maintaining a ~23% payout ratio despite the company's ongoing transition toward higher-margin flexible packaging chemicals.
Dividend per share: ₹1.5Face Value: ₹10Record Date: July 30, 2026TTM EPS: ₹6.57Dividend Payout Ratio: ~22.8%
📅 Short termThe stock may see minor price adjustments around the ex-dividend date as the dividend value is factored out of the share price.
📈 Long termLimited; this is a routine annual dividend distribution consistent with the company's historical financial performance.
Key Highlights
Final dividend declared at ₹1.5 per equity share of ₹10 face value
Record date for determining eligibility is July 30, 2026
97th Annual General Meeting scheduled for August 6, 2026
Dividend payout ratio stands at approximately 22.8% of TTM EPS of ₹6.57
Payment to be completed within 30 days of the AGM declaration
👀 What to Watch
Investors should ensure they hold the shares before the ex-dividend date (typically one business day prior to the July 30 record date) to be eligible for the payout.
IVP Resumes Operations at Tarapur Plant Following MPCB Revocation of Closure Order
IVP Limited has received a revocation order from the Maharashtra Pollution Control Board (MPCB) on July 09, 2026, allowing the immediate restart of its Tarapur manufacturing facility. This follows a closure direction issued on June 29, 2026, which resulted in an approximately 11-day operational halt. As the company operates only two manufacturing sites, the resumption is vital for maintaining its TTM revenue of Rs 267 Cr and its strategic shift toward high-margin flexible packaging.
Confidence: HIGH
What changedThe MPCB has officially allowed IVP to restart its Tarapur plant, ending a brief period of forced closure due to regulatory directions.
Why it mattersThe Tarapur plant is a core manufacturing hub; its resumption prevents a significant disruption in the production of Foundry and PU chemicals and ensures the company can continue its transition toward specialized packaging chemicals.
Revocation Date: July 09, 2026Closure Duration: ~11 daysTotal Manufacturing Sites: 2TTM Revenue: Rs 267 CrPlant Importance: 1 of 2 sites
📅 Short termThe removal of operational uncertainty regarding the Tarapur plant is likely to be viewed positively by the market in the coming days.
📈 Long termWhile the immediate crisis is resolved, the event highlights the regulatory sensitivity of chemical manufacturing; the long-term focus remains on the shift to high-margin Non-Foam applications.
⚠ Risk flags
- Environmental compliance risk
- Potential production loss for the shutdown period
Key Highlights
MPCB granted revocation of closure directions on July 09, 2026, for the Tarapur facility.
Operations at the D-19/20, MIDC Area, Tarapur plant to recommence with immediate effect.
The facility was under closure directions for approximately 11 days since the June 29, 2026, disclosure.
IVP operates only 2 state-of-the-art manufacturing sites, making this facility critical to production.
The company reported TTM revenue of Rs 267 Cr and a PAT of Rs 7 Cr prior to this event.
👀 What to Watch
Monitor the upcoming quarterly results for any production loss or one-off compliance costs incurred during the 11-day shutdown. Watch for any further environmental compliance updates to ensure no recurring regulatory risks at the Tarapur site.
MPCB Orders Immediate Closure of Tarapur Manufacturing Unit
IVP Limited has received a closure order from the Maharashtra Pollution Control Board (MPCB) for its manufacturing facility located in Tarapur, Maharashtra, effective June 29, 2026. The order cites alleged violations of the Water (Prevention and Control of Pollution) Act and the Air (Prevention and Control of Pollution) Act. As the company operates only two manufacturing sites, the shutdown of one unit represents a significant operational risk relative to its TTM revenue of ₹267 Cr. The company is currently taking measures to address regulatory concerns, though the exact financial impact is not yet quantified.
Confidence: HIGH
What changedThe Maharashtra Pollution Control Board has mandated the immediate shutdown of IVP's Tarapur manufacturing unit due to environmental non-compliance.
Why it mattersThis is a major regulatory setback; since the company only has two manufacturing sites, the closure of one could lead to a substantial drop in production capacity and revenue until compliance is met.
Total Manufacturing Sites: 2Units Ordered Closed: 1TTM Revenue: ₹267 CrOrder Receipt Date: June 29, 2026
📅 Short termExpect immediate pressure on the stock and operational disruption as production at the Tarapur site halts.
📈 Long termWhile the company is shifting toward high-margin specialized chemicals, recurring regulatory hurdles or prolonged shutdowns could derail its growth strategy and margin expansion goals.
⚠ Risk flags
- Regulatory non-compliance
- Operational disruption
- Revenue concentration risk (one of two plants)
- Potential legal penalties
Key Highlights
Closure order received on June 29, 2026, for the unit at D-19/20, MIDC Area Tarapur.
Action initiated under Section 33A of the Water Act and Section 31A of the Air Act.
The affected facility is one of only 2 state-of-the-art manufacturing sites operated by the company.
TTM revenue of ₹267 Cr and TTM PAT of ₹7 Cr are at risk depending on the duration of the shutdown.
Manufacturing operations ordered to cease with immediate effect.
👀 What to Watch
Investors should monitor the timeline for the company to rectify the alleged environmental violations and the subsequent application for a 'revocation of closure' order from the MPCB.
IVP Ltd Faces ₹136.82 Crore Claim and Eviction Order from Mumbai Port Trust
IVP Limited has received an adverse order from the Estate Officer of the Mumbai Port Authority (MBPT) regarding a long-standing lease dispute in Mumbai. The order demands a total payment of ₹136.81 crore, comprising ₹56.84 crore in compensation and ₹79.97 crore in damages, inclusive of taxes and interest. This dispute dates back to 2006, with the company arguing that MBPT's rent revisions violate a 2004 Supreme Court order. While the company has previously disclosed a contingent liability of ₹92.59 crore, this new claim is significantly higher and includes an eviction order.
Key Highlights
Estate Officer of Mumbai Port Authority passed an order for eviction and payment of damages against IVP Limited.
Total financial claim amounts to ₹136,81,52,795.95, including compensation and damages.
The dispute involves inconsistent rent billing by MBPT since September 2006.
The company intends to challenge the order via Statutory Appeals and Writ Petitions in the City Civil Court and Bombay High Court.
The current claim exceeds the previously disclosed contingent liability of ₹92.59 crore.
👀 What to Watch
Investors should exercise caution as the claim amount is very high relative to the company's typical valuation and could significantly impact the balance sheet if the legal challenges fail. Monitor the Bombay High Court's upcoming judgment on the reserved Writ Petition for further clarity.
IVP Limited Reports Strong FY26 Performance with 65% PAT Growth to ₹18.68 Crore
IVP Limited delivered a robust financial performance for FY26, with revenue growing 10% to ₹594.55 crore and Profit After Tax (PAT) surging 65% to ₹18.68 crore. The company's EBITDA margins improved by 114 basis points to 6.48%, driven by operational efficiencies and disciplined cost management. Despite one-off provisions for new labor codes and a sales-related internal control issue, underlying performance remained strong across its core foundry and polyurethane verticals. The management remains optimistic about domestic market expansion and leveraging its diversified product portfolio.
Key Highlights
Full-year FY26 PAT increased by 65% year-on-year to ₹18.68 crore
Q4 FY26 PAT saw a massive 131% jump to ₹8.86 crore compared to ₹3.83 crore in Q4 FY25
Annual EBITDA grew by 34% to ₹38.52 crore, with margins expanding to 6.48%
Revenue from operations for FY26 reached ₹594.55 crore, a 10% increase over the previous year
Company successfully managed one-off impacts related to labor codes and internal control investigations while maintaining growth
👀 What to Watch
Investors should view the significant margin expansion and triple-digit Q4 PAT growth as a positive sign of operational turnaround. Monitor the company's ability to scale its Polyurethane business and maintain internal controls following the reported sales-related discrepancy.
IVP Limited Faces Civil Suit from Accused Employee in Ongoing Fraud Case
IVP Limited has provided an update regarding an ongoing fraud case involving a former sales employee, Mr. Ravi Ranjan Jha. The accused has filed a civil suit against the company and its officials in the court at Gautam Budh Nagar, Greater Noida. This follows multiple disclosures regarding the fraud matter that began in January 2026. The company has stated that the claims made in the suit are not tenable and it will take legal action to defend its interests.
Key Highlights
Accused employee Mr. Ravi Ranjan Jha filed a civil suit against IVP Limited and its officials.
The legal action is being contested in Gautam Budh Nagar, Greater Noida, Uttar Pradesh.
This update follows five previous intimations regarding the fraud matter since January 13, 2026.
IVP Limited intends to vigorously defend itself, claiming the suit's allegations are without merit.
👀 What to Watch
Investors should monitor the progress of the fraud investigation and the potential financial recovery or loss. The civil suit by the accused is a secondary development, but it highlights the ongoing nature of this internal control issue.
IVP Limited Reports Rs 6.13 Crore Employee Fraud; Accused Taken Into Custody
IVP Limited has updated the exchanges regarding a fraud committed by a sales employee, Mr. Ravi Ranjan Jha, involving an amount of Rs. 613 lakhs. The accused has been taken into police custody by the Byculla Police Station for further investigation following the FIR filed by the company. The financial impact is confirmed at Rs. 6.13 crore, which may affect the company's bottom line. In response, the company has implemented a more robust customer onboarding process to prevent such lapses in the future.
Key Highlights
Actual financial impact of the fraud is quantified at Rs. 613 lakhs (Rs. 6.13 Crore).
Accused sales employee, Mr. Ravi Ranjan Jha, has been taken into police custody.
The fraud was reported to the Byculla Police Station under a formal FIR.
Corrective measures include making the customer onboarding process more robust.
👀 What to Watch
Investors should monitor the potential for fund recovery and the impact of this Rs. 6.13 crore loss on the company's upcoming financial statements. The incident highlights a significant weakness in internal controls that warrants a cautious approach until governance improvements are proven effective.
Universus Photo FY26 Net Profit Drops 39% to ₹19.26 Cr; Revenue from Operations Down 24%
Universus Photo Imagings Limited reported a significant decline in its financial performance for the fiscal year ended March 31, 2026. Annual net profit fell to ₹1,926 lakhs from ₹3,175 lakhs in the previous year, while revenue from operations decreased from ₹2,460 lakhs to ₹1,878 lakhs. The company's bottom line remains heavily dependent on 'Other Income' (₹2,094 lakhs), which also saw a sharp reduction from the previous year's ₹4,223 lakhs.
Key Highlights
Annual Net Profit declined by 39.3% YoY to ₹1,926 lakhs in FY26.
Revenue from operations for FY26 fell 23.6% YoY to ₹1,878 lakhs.
Other Income, a primary profit driver, halved from ₹4,223 lakhs in FY25 to ₹2,094 lakhs in FY26.
Earnings Per Share (EPS) dropped significantly to ₹17.59 from ₹29.00 in the previous fiscal year.
Non-current investments increased to ₹400.86 crore, representing the bulk of the company's asset base.
👀 What to Watch
Investors should exercise caution as the company's core operations are shrinking and profitability is largely driven by investment/other income rather than business growth. Monitor the quality of the investment portfolio which constitutes the majority of the balance sheet.
IVP Limited Recommends 15% Dividend and Re-appoints Key Directors
IVP Limited's Board has recommended a final dividend of Rs. 1.5 per share (15%) for the financial year ended March 31, 2026. The company also announced the re-appointment of two Independent Directors and its Statutory Auditors for second five-year terms, ensuring management and oversight continuity. The financial results for the year were audited with an unmodified opinion by Rajendra & Co. These proposals will be placed before shareholders at the 97th Annual General Meeting for final approval.
Key Highlights
Recommended a final dividend of 15% (Rs. 1.5 per share) for the financial year ended March 31, 2026.
Re-appointed Independent Directors Mr. Ranjeev Ugamraj Lodha and Ms. Mala Arun Todarwal for second 5-year terms.
Proposed re-appointment of Statutory Auditors M/s. Rajendra & Co. for a second term of five consecutive years until 2031.
Appointed M/s. Kishore Bhatia & Associates as Cost Auditors for the financial year 2026-27.
Statutory Auditors issued an unmodified audit opinion on the annual financial results.
👀 What to Watch
Investors should benefit from the 15% dividend payout and can view the continuity in the board and auditing firm as a sign of corporate stability. Monitor the upcoming AGM for the formal approval of these resolutions.
IVP Ltd Recommends 15% Dividend and Re-appoints Auditors for 5-Year Term
IVP Limited's Board has recommended a final dividend of Rs. 1.5 per share (15%) for the financial year ended March 31, 2026. The company reported audited financial results with an unmodified opinion from statutory auditors M/s. Rajendra & Co. Furthermore, the Board approved the re-appointment of M/s. Rajendra & Co. as Statutory Auditors for a second five-year term until 2031. Additionally, two Independent Directors were re-appointed for five-year terms, ensuring leadership continuity.
Key Highlights
Recommended a final dividend of 15% (Rs. 1.5 per equity share of Rs. 10 face value) for FY 2025-26
Re-appointed M/s. Rajendra & Co. as Statutory Auditors for a second 5-year term until the 102nd AGM in 2031
Statutory Auditors issued an unmodified opinion on the annual audited financial results for the year ended March 31, 2026
Re-appointed Independent Directors Mr. Ranjeev Ugamraj Lodha and Ms. Mala Arun Todarwal for second 5-year terms
👀 What to Watch
Investors should benefit from the proposed dividend and the stability in the company's auditing and governance framework. Monitor the upcoming Annual General Meeting for formal approval of these proposals.
IVP Limited Recommends 15% Final Dividend (Rs. 1.5/Share) for FY 2025-26
IVP Limited's Board of Directors has recommended a final dividend of Rs. 1.5 per equity share, representing 15% of the face value, for the financial year ended March 31, 2026. The company also released its audited financial results for the same period, which received an unmodified opinion from statutory auditors. Key management decisions include the re-appointment of statutory auditors and two independent directors for five-year terms. The dividend is subject to shareholder approval at the upcoming 97th Annual General Meeting.
Key Highlights
Recommended a final dividend of Rs. 1.5 per equity share (15% on face value of Rs. 10).
Approved audited financial results for the quarter and financial year ended March 31, 2026.
Statutory auditors M/s. Rajendra & Co. issued an unmodified audit report.
Re-appointed Statutory Auditors for a second term of five years until 2031.
Re-appointed Independent Directors Mr. Ranjeev Ugamraj Lodha and Ms. Mala Arun Todarwal for 5-year terms.
👀 What to Watch
Investors should check the upcoming Annual General Meeting date and record date to ensure eligibility for the Rs. 1.5 per share dividend. Review the detailed audited financial statements to evaluate the company's operational performance for the full year.
IVP Ltd Recommends 15% Final Dividend and Approves Audited FY26 Financial Results
IVP Limited has approved its audited financial results for the fiscal year ending March 31, 2026, and recommended a final dividend of Rs. 1.5 per share (15% of face value). The company is maintaining governance stability by re-appointing its statutory auditors, M/s. Rajendra & Co., for a second five-year term. Additionally, two independent directors have been re-appointed for five-year terms, and the statutory auditors issued an unmodified opinion on the financial statements. These moves indicate a focus on management continuity and shareholder returns.
Key Highlights
Recommended a final dividend of 15% (Rs. 1.5 per share) on equity shares of Rs. 10 each for FY 2025-26.
Re-appointed M/s. Rajendra & Co. as Statutory Auditors for a second 5-year term until the conclusion of the 102nd AGM in 2031.
Re-appointed Independent Directors Mr. Ranjeev Ugamraj Lodha and Ms. Mala Arun Todarwal for second 5-year terms starting mid-2026.
Statutory Auditors issued an audit report with an unmodified opinion for the financial year ended March 31, 2026.
👀 What to Watch
Investors should review the detailed financial statements to assess year-on-year growth trends and maintain positions given the stable governance and dividend payout. The dividend is subject to approval at the upcoming 97th Annual General Meeting.
